Catalyst
Slingshot members are tracking this event:
Phase 2 data of TRC105 and Nexavar for Hepatocellular carcinoma due 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TCON | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 05, 2017
Occurred Source:
http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2278910
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Trc105, Nexavar, Hepatocecllular Carcinoma, Phase 2
